Contribution of β-lactamases to β-lactam susceptibilities of susceptible and multidrug-resistant Mycobacterium tuberculosis clinical isolates

被引:24
作者
Segura, C
Salvadó, M
Collado, I
Chaves, J
Coira, A
机构
[1] Univ Autonoma Barcelona, Lab Referencia Catalunya, E-08193 Barcelona, Spain
[2] Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain
[3] Inst Municipal Invest Med, E-08003 Barcelona, Spain
关键词
D O I
10.1128/AAC.42.6.1524
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The beta-lactamases in 154 clinical Mycobacterium tuberculosis strains were studied. Susceptibilities to beta-lactam antibiotics, their combination with clavulanate (2:1), and two fluoroquinolones were determined in 24 M. tuberculosis strains susceptible to antimycobacterial drugs and in nine multiresistant strains, All 154 M. tuberculosis isolates shelved a single chromosomal beta-lactamase pattern (pI 4.9 and 5.1). M. tuberculosis beta-lactamase hydrolyzes cefotaxime with a maximum rate of 22.5 +/- 2.19 IU/liter (strain 1382). Neither amoxicillin, carbenicillin, cefotaxime, ceftriaxone, nor aztreonam was active alone. Except for aztreonam, beta-lactam combinations with clavulanate produced better antimycobacterial activity.
引用
收藏
页码:1524 / 1526
页数:3
相关论文
共 25 条
[1]   CHARACTERIZATION OF A BETA-LACTAMASE PRODUCED IN MYCOBACTERIUM-FORTUITUM D316 [J].
AMICOSANTE, G ;
FRANCESCHINI, N ;
SEGATORE, B ;
ORATORE, A ;
FATTORINI, L ;
OREFICI, G ;
VANBEEUMEN, J ;
FRERE, JM .
BIOCHEMICAL JOURNAL, 1990, 271 (03) :729-734
[2]   TUBERCULOSIS - COMMENTARY ON A REEMERGENT KILLER [J].
BLOOM, BR ;
MURRAY, CJL .
SCIENCE, 1992, 257 (5073) :1055-1064
[3]   RESURGENT TUBERCULOSIS IN NEW-YORK-CITY - HUMAN-IMMUNODEFICIENCY-VIRUS, HOMELESSNESS, AND THE DECLINE OF TUBERCULOSIS-CONTROL PROGRAMS [J].
BRUDNEY, K ;
DOBKIN, J .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (04) :745-749
[4]   METHODOLOGY FOR THE STUDY OF BETA-LACTAMASES [J].
BUSH, K ;
SYKES, RB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (01) :6-10
[5]   A FUNCTIONAL CLASSIFICATION SCHEME FOR BETA-LACTAMASES AND ITS CORRELATION WITH MOLECULAR-STRUCTURE [J].
BUSH, K ;
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1211-1233
[6]  
BUSH K, 1984, METHOD ENZYMAT AN, V4, P280
[7]   INVITRO SUSCEPTIBILITY OF MYCOBACTERIUM-TUBERCULOSIS, MYCOBACTERIUM-FORTUITUM AND MYCOBACTERIUM-CHELONEI TO AUGMENTIN [J].
CASAL, M ;
RODRIGUEZ, F ;
BENAVENTE, M ;
LUNA, M .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (04) :453-454
[8]   INVITRO SUSCEPTIBILITY OF MYCOBACTERIUM-TUBERCULOSIS, MYCOBACTERIUM-AFRICANUM, MYCOBACTERIUM-BOVIS, MYCOBACTERIUM-AVIUM, MYCOBACTERIUM-FORTUITUM, AND MYCOBACTERIUM-CHELONAE TO TICARCILLIN IN COMBINATION WITH CLAVULANIC ACID [J].
CASAL, MJ ;
RODRIGUEZ, FC ;
LUNA, MD ;
BENAVENTE, MC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (01) :132-133
[9]   CAN PENICILLINS AND OTHER BETA-LACTAM ANTIBIOTICS BE USED TO TREAT TUBERCULOSIS [J].
CHAMBERS, HF ;
MOREAU, D ;
YAJKO, D ;
MIICK, C ;
WAGNER, C ;
HACKBARTH, C ;
KOCAGOZ, S ;
ROSENBERG, E ;
HADLEY, WK ;
NIKAIDO, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (12) :2620-2624
[10]   INVITRO ACTIVITY OF AMOXICILLIN IN COMBINATION WITH CLAVULANIC ACID AGAINST MYCOBACTERIUM-TUBERCULOSIS [J].
CYNAMON, MH ;
PALMER, GS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (03) :429-431